Real-time enrollment status for this advanced cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT06413680 |
| Recruiting Status | Recruiting |
| Condition | Advanced Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | December 15, 2025 (Dec 15, 2025) |
As of March 2, 2026: Clinical trial NCT06413680 is currently recruiting participants. This clinical trial study for advanced cancer is actively seeking new participants at 11 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06413680 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06413680 was last updated Dec 15, 2025 (December 15, 2025). HelloStudys verifies this status automatically.